Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Solitary Fibrous Tumors 1Sarcoma 1Liposarcoma 1Leukemia, Hairy Cell 1Histiocytoma, Malignant Fibrous 1Dermatofibrosarcoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Specimen Handling 4Radiotherapy 4Radiation 4Nivolumab 4pembrolizumab 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Doxorubicin 3CTLA-4 Antigen 3Biopsy 3talimogene laherparepvec 1peposertib 1pazopanib 1liposomal doxorubicin 1fludarabine 1cabozantinib 1aldesleukin 1X-Rays 1Trabectedin 1Ifosfamide 1Histamine H2 Antagonists 1Famotidine 1Dactinomycin 1Cyclophosphamide 1BO-112 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytoma, Malignant Fibrous × Famotidine × 90 days × Clear all
NCT06789172 2026-05-22

INVOKE

Epkin

Phase 1 Recruiting
166 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Liposarcoma, Sarcoma, Colorectal Neoplasms, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡